Alzheimer's disease is a neurologic degenerative disorder that causes the brain to shrink and brain cells to die. Alzheimer's disease is the most common form of dementia, which is characterised by a continuous decline in mental, behavioural, and social skills and reduces a person's capacity for independent living. 5.8 million Americans over the age of 65 suffer from Alzheimer's disease. They range in age from 75 and older by 80%. It is believed that Alzheimer's disease affects between 60% and 70% of the estimated 50 million dementia sufferers worldwide. Forgetting earlier encounters or occurrences is one of the illness' early warning signals. A person with Alzheimer's disease will have severe memory loss and lose the capacity to carry out basic duties. With medication, symptoms could momentarily become better or progress more slowly. Sometimes, these therapies can help patients with Alzheimer's disease maintain their independence and function at their highest level. The people who have Alzheimer's disease and those who care for them can access a wide range of services and programmes. As of right now, there is no drug for Alzheimer's that can halt the disease's progression in the brain. Extremely advanced stages of the condition might result in mortality from major loss of brain function-related issues like dehydration, hunger, or infection This Scholarly Publishing, Open Access journal aims to publish the most reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available online without any restrictions or subscriptions to the researchers worldwide.